Project: Developing a complete cervical cancer screening solution based on first-void urine self-sampling

Acronym CASUS (Reference Number: 12396)
Duration 01/10/2018
Project Topic We want to develop the first complete molecular screening solution for cervical cancer (CC), based on standardized self-collected first-void urine to maximize screening participation throughout the EU. CASUS will result in a next-generation user-friendly first-void urine collector, combined with an integrated diagnostic approach for 1) detection of human papillomavirus (HPV) infection and 2) triage after a HPV+ result to identify women with CC or precursor lesions in need of colposcopy.
Network Eurostars 2
Call Eurostars Cut–off 9

Project partner

Number Name Role Country
1 Self-screen B.V. Coordinator Netherlands
2 Novosanis Partner Belgium